Faculty of Pharmacy, The University of Sydney, Sydney, New South Wales, Australia.
Drugs Aging. 2010 Feb 1;27(2):135-48. doi: 10.2165/11531560-000000000-00000.
A significant problem in older people (aged >or=65 years) is the use of potentially inappropriate medications (PIMs), including those with sedative and anticholinergic properties. However, effective intervention strategies have yet to be identified. The Drug Burden Index (DBI) is an evidence-based tool that measures a person's total exposure to medications with sedative and anticholinergic properties and has been shown to be independently associated with impairment in cognitive and physical function.
The main aim of the study was to investigate whether Home Medicines Review (HMR) services by pharmacists for community-dwelling older people would lead to an improvement in the use of medications, as measured by a decrease in the DBI score. The study also aimed to investigate the (i) distribution of DBI scores and PIMs among older people living in the community, and (ii) impact of pharmacists' recommendations on DBI scores and PIMs.
A retrospective analysis of medication reviews was performed for 372 community-dwelling older people (aged >or=65 years) who received an HMR service from the pharmacist. The main outcome measure was the total DBI score at baseline and post-HMR. The data were also examined to determine the extent of PIM use (2003 Beers' criteria), and the number and nature of pharmacists' recommendations.
Overall, medications contributing to the DBI (i.e. medications with sedative or anticholinergic properties) and PIMs were identified in 60.5% (n = 225) and 39.8% (n = 148) of the patients, respectively. Following pharmacist recommendations during the HMR service, medications contributing to the DBI were identified in 51.6% (n = 192) of the patients. A statistically significant reduction in the sum total of DBI scores for all patients was observed following pharmacists' recommendations during the HMR service (206.9 vs 157.3, p < 0.001). Pharmacists' recommendations also led to a decrease in the use of PIMs, which were identified in 28.2% (n = 105) of the patients following the HMR service.
When the DBI is used for evaluation, pharmacists' recommendations during HMR services, if acted upon, may effect changes in the prescribing of sedative and anticholinergic medications, thereby substantially reducing the patient's drug burden. Future studies should focus on whether such a decrease may translate into functional improvements. The study also showed a positive influence of HMR services on the prescribing of PIMs.
老年人(年龄大于或等于 65 岁)存在一个重大问题,即使用潜在不适当的药物(PIMs),包括具有镇静和抗胆碱能特性的药物。然而,目前尚未确定有效的干预策略。药物负担指数(DBI)是一种基于证据的工具,用于衡量一个人使用具有镇静和抗胆碱能特性的药物的总暴露情况,并且已经被证明与认知和身体功能的损害独立相关。
本研究的主要目的是研究药剂师为社区居住的老年人提供的家庭用药审查(HMR)服务是否会导致药物使用的改善,这可以通过 DBI 评分的降低来衡量。该研究还旨在调查:(i)社区居住的老年人的 DBI 评分和 PIMs 的分布情况;(ii)药剂师的建议对 DBI 评分和 PIMs 的影响。
对接受药剂师 HMR 服务的 372 名社区居住的老年人(年龄大于或等于 65 岁)的用药审查进行回顾性分析。主要的观察指标是基线和 HMR 后总 DBI 评分。还检查了 PIM 使用的程度(2003 年 Beers 标准),以及药剂师建议的数量和性质。
总体而言,在 60.5%(n=225)和 39.8%(n=148)的患者中分别发现了导致 DBI 的药物(即具有镇静或抗胆碱能特性的药物)和 PIMs。在 HMR 服务期间,根据药剂师的建议,导致 DBI 的药物在 51.6%(n=192)的患者中被发现。在 HMR 服务期间,根据药剂师的建议,所有患者的 DBI 总分均显著降低(206.9 比 157.3,p<0.001)。药剂师的建议还导致 PIM 使用的减少,在 HMR 服务后,有 28.2%(n=105)的患者使用了 PIMs。
当使用 DBI 进行评估时,如果根据 HMR 服务期间的药剂师建议进行调整,可能会改变镇静和抗胆碱能药物的处方,从而显著降低患者的药物负担。未来的研究应关注这种减少是否会转化为功能的改善。该研究还表明 HMR 服务对 PIM 处方有积极影响。